Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02419963 · ClinicalTrials.gov registry record · NA
Analyzing IBS to Identify Biomarkers and Microbiome Signatures
A NA study of IBS and Diarrhoea Predominant Irritable Bowel Syndrome, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
- 1
- Study location
NCT02419963 is a NA study of IBS and Diarrhoea Predominant Irritable Bowel Syndrome that has completed, run by Mayo Clinic. The registered enrollment target is 26 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02419963, a NA study of IBS and Diarrhoea Predominant Irritable Bowel Syndrome, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
- 1
- Study location
Study Summary
Microbiota from fecal samples from IBS-D patients, in combination with vitamin D supplementation added to our 3-D immunocompetent intestinal models will establish a high fidelity disease model to achieve our long-term goal to understand the relationship between gut microbiome, vitamin D levels, host gene expression and IBS-D symptoms that could ultimately be used as a testing platform for treatment and prevention.
Conditions Studied
Interventions
- OTHER Blood Sample
- PROCEDURE endoscopy for tissue biopsy
- OTHER Stool Sample
Study Locations (1)
Arizona
- Mayo Clinic in Arizona - Scottsdale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2015-05 |
| Est. Completion | 2016-12-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02419963
The ClinicalTrials.gov registry entry for NCT02419963 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with IBS appearing as the primary indexed condition, and to 3 interventions - of which Blood Sample is the first listed.
NCT02419963 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.
Frequently Asked Questions
What is clinical trial NCT02419963 about?
NCT02419963 is a clinical study titled "Analyzing IBS to Identify Biomarkers and Microbiome Signatures". Microbiota from fecal samples from IBS-D patients, in combination with vitamin D supplementation added to our 3-D immunocompetent intestinal models will establish a high fidelity disease model to achieve our long-term goal to understand the relationship between gut microbiome, vitamin D levels, host...
What is the current status of trial NCT02419963?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2015-05. Estimated completion is 2016-12-12.
What conditions does trial NCT02419963 study?
This clinical trial studies the following conditions: IBS, Diarrhoea Predominant Irritable Bowel Syndrome.
What interventions are being tested in trial NCT02419963?
The interventions under investigation include: Blood Sample (OTHER), endoscopy for tissue biopsy (PROCEDURE), Stool Sample (OTHER).
Who is sponsoring clinical trial NCT02419963?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02419963 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for IBS
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.